03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Mark David Orland: no photograph is held, so the academic plate is shown instead.
Academic
Mark David Orland
MD, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
1
0
0
0
0
0
0
May 2026JuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 21 May 2026 · last quoted 21 May 2026
02 Quoted on · 1 of 29 topics
Mark David Orland: key facts
- Kind of voice
- Academic
- Role
- MD, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
- Quoted on
- Cancer
- Tracked press citations
- 1
- Most recently quoted
- 21 May 2026
04 On the record · press
What Mark David Orland has said
By outlet · linked articles
- oncology-central.com1
Where Mark David Orland has been quoted
- 01ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressingoncology-central.com · 21 May 2026
Verbatim
“Our study found that use of GLP-1 drugs, compared to DPP-4 inhibitors and other antidiabetic drugs, was associated with a meaningful reduction in cancer progression across 4 solid tumor types. It provides early evidence that future studies are worth pursuing.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.